Role of the nitric oxide-cyclic GMP-K+ channel pathway in the antinociception induced by atrial natriuretic peptide (ANP) and diclofenac.
Ortiz
Mario I
MI
Sección Externa de Farmacología, Centro de Investigación y de Estudios Avanzados del IPN, México, D.F., Mexico.
Torres-López
Jorge E
JE
Castañeda-Hernández
Gilberto
G
Rosas
Rodolfo
R
Vidal-Cantú
Guadalupe C
GC
Granados-Soto
Vinicio
V
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D009320:Atrial Natriuretic Factor / Q000494:pharmacology*; D018999:Charybdotoxin / Q000494:pharmacology; D006152:Cyclic GMP / Q000378:metabolism / Q000502:physiology*; D004008:Diclofenac / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D005557:Formaldehyde; D005905:Glyburide / Q000494:pharmacology; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D010069:Oxadiazoles / Q000494:pharmacology; D010147:Pain Measurement / Q000187:drug effects; D015221:Potassium Channels / Q000502:physiology*; D011810:Quinoxalines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D014044:Tolbutamide / Q000494:pharmacology
C095284:1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one; D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004791:Enzyme Inhibitors; D010069:Oxadiazoles; D015221:Potassium Channels; D011810:Quinoxalines; D018999:Charybdotoxin; D004008:Diclofenac; D005557:Formaldehyde; D009569:Nitric Oxide; D009320:Atrial Natriuretic Factor; D014044:Tolbutamide; D019001:Nitric Oxide Synthase; D006152:Cyclic GMP; D005905:Glyburide; D019331:NG-Nitroarginine Methyl Ester